These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
775 related articles for article (PubMed ID: 34477077)
1. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid. Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077 [TBL] [Abstract][Full Text] [Related]
2. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities. Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720 [TBL] [Abstract][Full Text] [Related]
3. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis. Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081 [TBL] [Abstract][Full Text] [Related]
4. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies. Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X Front Immunol; 2022; 13():903174. PubMed ID: 35720393 [TBL] [Abstract][Full Text] [Related]
5. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid. Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242 [TBL] [Abstract][Full Text] [Related]
6. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases. Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T Front Immunol; 2021; 12():771766. PubMed ID: 34899722 [TBL] [Abstract][Full Text] [Related]
7. Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement. Quattri E; Zussino M; Lauro W; Berti E; Marzano AV; Genovese G Front Med (Lausanne); 2022; 9():1000954. PubMed ID: 36186772 [TBL] [Abstract][Full Text] [Related]
8. Anti-BP180-type mucous membrane pemphigoid: report of two cases. Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555 [TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049 [TBL] [Abstract][Full Text] [Related]
10. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration. Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T J Dermatol; 2024 Jun; 51(6):869-872. PubMed ID: 38214494 [TBL] [Abstract][Full Text] [Related]
11. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies. Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468 [TBL] [Abstract][Full Text] [Related]
13. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia. Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447 [TBL] [Abstract][Full Text] [Related]
14. Mucous membrane pemphigoid. Du G; Patzelt S; van Beek N; Schmidt E Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762 [TBL] [Abstract][Full Text] [Related]
15. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum. Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183 [TBL] [Abstract][Full Text] [Related]
16. A Case of IgG and IgA Anti-Laminin-332 Antibody-Positive Mucous Membrane Pemphigoid with IgG and IgA Anti-Envoplakin and Anti-Periplakin Antibodies. Matsushima Y; Kitano M; Hayashi D; Goto H; Mine M; Yokoe T; Kondo M; Habe K; Toiyama Y; Hashimoto T; Tsuruta D; Takeuchi K; Yamanaka K Dermatopathology (Basel); 2022 Aug; 9(3):287-291. PubMed ID: 35997351 [TBL] [Abstract][Full Text] [Related]
17. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. Lazarova Z; Yancey KB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276 [TBL] [Abstract][Full Text] [Related]
19. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. Bekou V; Thoma-Uszynski S; Wendler O; Uter W; Schwietzke S; Hunziker T; Zouboulis CC; Schuler G; Sorokin L; Hertl M J Invest Dermatol; 2005 Apr; 124(4):732-40. PubMed ID: 15816831 [TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]